BioMedical Enterprises new Nitinol staple for extremities gains approval

HAMMERTOE DEVICE GAINS FDA CLEARANCE (Orthopedics This Week) Press Release    BME Website A device for treating hammertoe deformities has received FDA clearance. Called the HammerLock Nitinol Intramedullary Fixation System, the device is manufactured by the privately held BioMedical Enterprises, Inc. (BME), San Antonio, Texas. Company officials report that the device eliminates the use of wires and features a flat body design that resists rotation. In addition, the device has barbs that provide a secure fixation. According to PR Newswire this upgraded version of HammerLock is designed with a l...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top